Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Acrivon Therapeutics Inc....

    NASDAQ: ACRV · Real-Time Price · USD
    1.21
    -0.01 (-0.82%)
    At close: Jun 17, 2025, 3:27 PM

    Acrivon Therapeutics Common Stock Statistics

    Share Statistics

    Acrivon Therapeutics Common Stock has 31.36M shares outstanding. The number of shares has increased by 1.54% in one year.

    Shares Outstanding

    n/a
    		 31.36M

    Shares Change (YoY)

    n/a
    		 1.54%

    Shares Change (QoQ)

    n/a
    		 0.69%

    Owned by Institutions (%)

    n/a
    		 60.39%

    Shares Floating

    n/a
    		 22.16M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,618

    FTD / Avg. Volume

    n/a
    		 0.21%

    Short Selling Information

    The latest short interest is 1.05M, so 3.34% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.05M

    Short % of Shares Out

    n/a
    		 3.34%

    Short % of Float

    n/a
    		 8.91%

    Short Ratio (days to cover)

    n/a
    		 1.27

    Valuation Ratios

    The PE ratio is -25.25 and the forward PE ratio is -0.52. Acrivon Therapeutics Common Stock's PEG ratio is 0.28.

    PE Ratio

    n/a
    		 -25.25

    Forward PE

    n/a
    		 -0.52

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.4

    PB Ratio

    n/a
    		 11.51

    P/FCF Ratio

    n/a
    		 -29.72

    PEG Ratio

    n/a
    		 0.28
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Acrivon Therapeutics Common Stock.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 10.55, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 10.55

    Quick Ratio

    n/a
    		 10.55

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.05

    Debt / FCF

    n/a
    		 -0.05

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,074,080

    Employee Count

    n/a
    		 75

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -82.27% in the last 52 weeks. The beta is 1.56, so Acrivon Therapeutics Common Stock's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.56

    52-Week Price Change

    n/a
    		 -82.27%

    50-Day Moving Average

    n/a
    		 1.38

    200-Day Moving Average

    n/a
    		 5.25

    Relative Strength Index (RSI)

    n/a
    		 43.31

    Average Volume (20 Days)

    n/a
    		 777,087

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -89.2M

    Net Income

    n/a
    		 -80.56M

    EBITDA

    n/a
    		 -79.55M

    EBIT

    n/a
    		 -80.56M

    Earnings Per Share (EPS)

    n/a
    		 -0.24
    Full Income Statement

    Balance Sheet

    The company has 39.82M in cash and 3.65M in debt, giving a net cash position of 36.17M.

    Cash & Cash Equivalents

    n/a
    		 39.82M

    Total Debt

    n/a
    		 3.65M

    Net Cash

    n/a
    		 36.17M

    Retained Earnings

    n/a
    		 -196.98M

    Total Assets

    n/a
    		 176.35M

    Working Capital

    n/a
    		 137.78M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -65.67M and capital expenditures -2.77M, giving a free cash flow of -68.44M.

    Operating Cash Flow

    n/a
    		 -65.67M

    Capital Expenditures

    n/a
    		 -2.77M

    Free Cash Flow

    n/a
    		 -68.44M

    FCF Per Share

    n/a
    		 -0.2
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ACRV does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ACRV is $17, which is 1293.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $17

    Price Target Difference

    n/a
    		 1293.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 8
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -1.23

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist